Mumbai (Maharashtra) [India], April 29 (ANI/PRNewswire): Fineotex Chemical Limited (FCL), one of India’s leading and most progressive specialty chemical producer with a market leading position in international textile industry has announced robust financial numbers in Q4FY22.
HIGHLIGHTS OF CONSOLIDATED BUSINESS
Consolidated business represents the performance of FCL and its subsidiaries (FCL Group)
Consolidated Business Q4-FY22 vs Q4-FY21 (Y-o-Y basis)
The Revenue from Operations of the Group has increased to Rs. 12,139 Lakh from Rs. 7,502 Lakh. The Revenue from Operations registered a growth of ~ 62 per cent;
The Profit after tax (PAT) of the Group has increased to Rs. 1,700 Lakh from Rs. 1,195 Lakh. The PAT registered a growth of ~ 42 per cent;
The Operational EBITDA of the Group has increased to Rs. 2,152 Lakh from Rs. 1,285 Lakh. The Operational EBITDA registered a growth of ~ 67 per cent;
The EPS of the Group has increased to Rs. 1.5 per share from Rs. 1.0 per share. The EPS registered a growth of ~ 50 per cent;
Consolidated Business FYE March 2022 vs FYE March 2021 (Y-o-Y basis)
The Revenue from Operations of the Group has increased to Rs. 36,823 Lakh from Rs. 21,851 Lakh. The Revenue from Operations registered a growth of ~ 69 per cent;
The Operational EBITDA of the Group has increased to Rs. 7,121 Lakh from Rs. 4,057 Lakh. The Operational EBITDA registered a growth of ~ 76 per cent;
Final Dividend – The Board has recommended a final dividend subject to the approval of members at the ensuing Annual General Meeting @ 20 per cent i.e. Rs. 0.40 (PY Rs. 0.30) per Equity Share of Face Value of Rs. 2/- which represents 33 per cent Y-O-Y growth in the dividend.
Highlights of India Business:
India business represents the performance of FCL Standalone and FSPL (wholly-owned subsidiary in India)
India Business Q4-FY22 vs Q4-FY21 (Y-o-Y basis)
The Revenue from Operations of the Company has increased to Rs. 10,117 Lakh from Rs. 4,796 Lakh. The Revenue from Operations registered a growth of ~ 110 per cent;
The Profit after tax (PAT) of the Company has increased to Rs. 1,696 Lakh from Rs. 910 Lakh. The PAT registered a growth of ~ 86 per cent;
The Operational EBITDA of the Company has increased to Rs. 2,012 Lakh from Rs. 1,030 Lakh. The Operational EBITDA registered a growth of ~ 95 per cent;
India Business FYE March 2022 vs FYE March 2021 (Y-o-Y basis)
The Revenue from Operations of the Company has increased to Rs. 28,261 Lakh from Rs. 12,948 Lakh. The Revenue from Operations registered a growth of ~ 118 per cent;
The Operational EBITDA of the Company has increased to Rs. 6,191 Lakh from Rs. 3,122 Lakh. The Operational EBITDA registered a growth of ~ 98 per cent;
Working Capital Cycle – There have been continuous improvements in the working capital cycle over the periods mentioned below –
Consolidated business – Net working capital has been improved by 51 days.
India business – Net working capital has been improved by 47 days.
Volume Growth – For the current FYE March 2022 the Consolidated business has seen overall volume growth of 62 per cent compared to the previous FYE March 2021. India business has observed overall volume growth of 85 per cent compared to the Previous FYE 2021.
Commenting on the successful result, Surendrakumar Tibrewala, CMD, Fineotex Chemical, said, “We are thrilled to announce the tremendous growth numbers. We will continue to strengthen our position and expand into new, untapped markets. Our aim will be to develop our chemistries and enter into strategic alliances in order to strengthen our existing and new relationships in both the domestic and foreign markets. Our plant’s sustainability requirements will allow expansion and further utilisation, and with demand on the rise, we anticipate a bright future. These are exciting times for Fineotex, and we are excited about the progress that is being achieved and the chances that are heading our way. The Board has proposed a final dividend of Rs. 0.40 per share of face value Rs. 2.”
Commenting on the successful result, Sanjay Tibrewala, Executive Director and CFO, Fineotex Chemical, said, “We have continued our growth trajectory in the current year, attaining 69 per cent percent growth, achieving working capital efficiency, and boosting our EBITDA margins. With the onset of the pandemic, we focused on developing home care and hygiene specialities, a diversified but related division of non-toxic specialty chemical solutions. This emerging business has opened up substantial business openings and thus giving us the opportunity to tap into new markets. The new manufacturing hub at Ambernath is one of the several new investments by us. It was a logical and necessary step in expanding and strengthening our competitive position at a local and global level. The initial planned capacity of 36,000 MTA is being ramped up to 40,000 MTA to cater to growing demand. In terms of our future trajectory, we are currently working on an additional expansion 21,000 MT. Due to process efficiency achieved internally, our working capital has also shown constant improvement. Our advanced capabilities, along with strategic collaborations, position us well to sustain growth, add value to our clients and maximise shareholder value.”
FCL’s CEO, Arindam Choudhuri mentioned , “We have expanded our portfolio and are working on providing more solutions for textile companies as well as a more diverse product range. With these steps, we feel all stakeholders will be able to see an even more beneficial shift in the growth. We have made a significant contribution to the worldwide ESG and sustainability movement. We manufacture while protecting the environment’s long-term viability and are devoted to zero waste practices, as seen by our extensive certifications and accreditations. It has endeavored to efficiently manage the release of dangerous chemicals, most notably by launching Zero Discharge of Hazardous Chemicals programmes (ZDHC).”
Founded in 1979, Fineotex Chemical (BSE: 533333) (NSE: FCL) is leading specialty chemical producer and a solution provider, having a market leading position in the specialty chemicals, in the international business as well as the domestic textile industry.
The Company manufactures chemicals for the entire value chain for the textile industry including pre-treatment, dyeing, printing and finishing process. The Company has successfully expanded into home care, hygiene and drilling specialty chemicals sector which is already supporting the next phase of growth for the Company. The Company manufactures over 475 products and exports to over 69 countries.
The Company has manufacturing facilities in Mumbai and Ambernath, India and Selangor, Malaysia with combined capacity of 83,000 MT. The newly set up facility at Ambernath with capacity of 40,000 MT (initial planned capacity 36,000 MT) will cater to customers’ demand for existing textile specialties and the fast-growing home care and hygiene and drilling specialties business.
The subsidiary in Malaysia, Biotex Malaysia drives all the R&D initiatives of the Company and overall new product development. Biotex specializes in high end specialty finishing textile chemicals like water & oil repellents, anti-microbials, etc. for textiles. It has critical industry certifications such as Bluesign, Global Organic Textile Standard, REACH, Bhive, ISO 9001:2015, ZDHC and OEKO-Tex, which make the Company preferred choice for global textile manufacturers.
This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)